INCY Competitors & Rivals
Compare Incyte Corporation with top Biotechnology companies
Incyte Corporation
INCY - Healthcare
Market Cap
$20.9B
Price
$103.43
P/E Ratio
18.02
Revenue Growth
0.2%
Top Competitors
Side-by-Side Comparison
| Metric | INCY | AAPL | MSFT | GOOGL |
|---|---|---|---|---|
| Price | $103.43 | $261.05 | $470.67 | $335.97 |
| Market Cap | $20.9B | $3874.1B | $3498.6B | $4063.2B |
| P/E Ratio | 18.02 | 33.85 | 33.89 | 23.14 |
| Revenue Growth | 0.2% | 6.4% | 0.2% | 13.9% |
| Profit Margin | 0.2% | 0.3% | 0.4% | 0.3% |
Detailed Head-to-Head Comparisons
Get in-depth analysis comparing INCY with each competitor
Frequently Asked Questions
Who are INCY's main competitors?
INCY's main competitors include AAPL, MSFT, GOOGL, and other companies in the Biotechnology industry. These companies compete directly with Incyte Corporation for market share and customers.
How does INCY compare to its competitors?
INCY can be compared to competitors using metrics like market capitalization, P/E ratio, revenue growth, profit margins, and market share. Each competitor has different strengths - some may have better valuations while others have higher growth rates.
What are the best alternatives to INCY stock?
The best alternatives to INCY depend on your investment goals. For similar market exposure, consider AAPL or MSFT. For different risk profiles, research companies with varying market caps and growth trajectories in the Biotechnology sector.
Which is better: INCY or AAPL?
Comparing INCY vs AAPL requires analyzing valuation metrics, growth prospects, competitive advantages, and risk factors. Neither is universally "better" - the right choice depends on your investment strategy, risk tolerance, and market outlook.
What makes INCY different from its competitors?
Incyte Corporation differentiates itself through its unique business model, product offerings, market positioning, and competitive advantages. Factors like brand strength, innovation, operational efficiency, and financial health distinguish INCY from rivals.
Should I diversify across INCY and its competitors?
Diversifying across multiple companies in the same industry can reduce company-specific risk while maintaining sector exposure. However, this doesn't eliminate sector risk. Consider diversifying across different industries and sectors for better risk-adjusted returns.
Continue Your Research
Explore more analysis tools for INCY